1 – 74 of 74
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults (
- Relevance of biomarkers across different neurodegenerative (
- Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg (
- The properties of α-synuclein secondary nuclei are dominated by the solution conditions rather than the seed fibril strain (
- Why Is Amyloid-β PET Requested After Performing CSF Biomarkers? (
- Secondary Nucleation in Amyloid Formation (
- Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein (
- Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors (
- The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils (
- Kinetic diversity of amyloid oligomers (
- Amyloid-specific extraction using organic solvents (
- Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease (
- 2019
- APP depletion alters selective pre- and post-synaptic proteins (
- Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort : The ABIDE project (
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences (
- A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies (
- Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort (
- 2018
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease (
- The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable (
- Prion-like seeding and nucleation of intracellular amyloid-β (
- Amyloid pathology in the progression to mild cognitive impairment (
- Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia (
- Preparation and culturing of human primary vascular cells (
- On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations (
- Amyloid network topology characterizes the progression of Alzheimer's disease during the predementia stages (
- Sex-specific genetic predictors of Alzheimer’s disease biomarkers (
- Abnormal structural brain connectome in individuals with preclinical Alzheimer's disease (
- 2017
- Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype (
- The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation (
- Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease. (
- Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline (
- Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40) (
- Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study (
- 2016
- Analysis of the length distribution of amyloid fibrils by centrifugal sedimentation (
- Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information (
- Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes (
- 2014
- The chaperone domain BRICHOS prevents CNS toxicity of amyloid-beta peptide in Drosophila melanogaster (
- Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C A ROLE FOR AMYLOID IN MALE INFERTILITY (
- Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA) (
- Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I (
- 2013
- Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy. (
- Fluid biomarkers in Alzheimer's disease - current concepts (
- A beta 1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases (
- 2012
- Monte Carlo studies of protein aggregation (
- Distinct phases of free α-synuclein - A Monte Carlo study. (
- Critical role of intraneuronal A beta in Alzheimer's disease: Technical challenges in studying intracellular A beta (
- Intraneuronal A beta Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer's Disease (
- 2011
- Monte Carlo Study of the Formation and Conformational Properties of Dimers of Aβ42 Variants. (
- Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population (
- 2010
- Amyloid beta-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process (
- Crystal structure of human cystatin C stabilized against amyloid formation (
- Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid beta Protein Fibrillation (
- Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain (
- Synapses, synaptic activity and intraneuronal Aβ in Alzheimer's disease (
- Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer's disease (
- Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses (
- 2009
- A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide (
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders (
- Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease (
- Dementia (
- Immunotherapy for Alzheimer disease (
- 2007
- Nucleation of protein fibrillation by nanoparticles (
- 2006
- Lactadherin binds to elastin - a starting point for medin amyloid formation? (
- 2005
- 3D domain-swapped human cystatin c with amyloidlike intermolecular beta-sheets (
- Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses (
- Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease (
- Intraneuronal β-amyloid expression downregulates the Akt survival pathway and blunts the stress response (
- 2004
- Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers (
- Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain (
- 2001
- Diffuse primary plasmacytoma of the lung (
- 2000
- L68Q cystatin C: Expression, cellular transport and turnover of the cystatin C variant forming amyloid in patients with Hereditary Cystatin C Amyloid Angiopaty (HCCAA) (
- 1997
- Islet amyloid polypeptide and calcitonin gene-related peptide expression are upregulated in lumbar dorsal root ganglia after unilateral adjuvant-induced inflammation in the rat paw (
- Islet amyloid polypeptide and calcitonin gene-related peptide expression are down-regulated in dorsal root ganglia upon sciatic nerve transection (
- 1996
- Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism (